HNSBF OTC
Hansa Biopharma AB
1W: -11.1%
1M: -11.1%
3M: +13.4%
YTD: +13.1%
1Y: +9.7%
$3.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$189M
Revenue
-3.7% YoY
$-768M
Net Income
-28.9% YoY
$-545M
Free Cash Flow
+12.1% YoY
53.6%
Gross Margin
-361.9%
Op. Margin
-541.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE159.8%
ROA-80.5%
ROIC1182.7%
Valuation
P/E-4.2
P/B-6.5
EV/EBITDA0.0
Leverage
Debt/Equity-1.99
Current Ratio1.25
Interest Cov.-3.1x
Quality Scores
Piotroski F2/9
Altman Z—
Beneish M-3.74